annual total liabilities:
$994.40M-$230.20M(-18.80%)Summary
- As of today (August 16, 2025), UTHR annual total liabilities is $994.40 million, with the most recent change of -$230.20 million (-18.80%) on December 31, 2024.
- During the last 3 years, UTHR annual total liabilities has fallen by -$245.80 million (-19.82%).
- UTHR annual total liabilities is now -22.84% below its all-time high of $1.29 billion, reached on December 31, 2022.
Performance
UTHR Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$734.40M-$202.30M(-21.60%)Summary
- As of today (August 16, 2025), UTHR quarterly total liabilities is $734.40 million, with the most recent change of -$202.30 million (-21.60%) on June 30, 2025.
- Over the past year, UTHR quarterly total liabilities has dropped by -$291.60 million (-28.42%).
- UTHR quarterly total liabilities is now -47.11% below its all-time high of $1.39 billion, reached on March 31, 2019.
Performance
UTHR quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
UTHR Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | -28.4% |
| 3 y3 years | -19.8% | -40.0% |
| 5 y5 years | -15.6% | -34.8% |
UTHR Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | at low | -44.0% | at low |
| 5 y | 5-year | -22.8% | at low | -44.0% | at low |
| alltime | all time | -22.8% | >+9999.0% | -47.1% | >+9999.0% |
UTHR Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $734.40M(-21.6%) |
| Mar 2025 | - | $936.70M(-5.8%) |
| Dec 2024 | $994.40M(-18.8%) | $994.40M(-2.7%) |
| Sep 2024 | - | $1.02B(-0.4%) |
| Jun 2024 | - | $1.03B(-11.3%) |
| Mar 2024 | - | $1.16B(-5.5%) |
| Dec 2023 | $1.22B(-5.0%) | $1.22B(-6.6%) |
| Sep 2023 | - | $1.31B(+3.2%) |
| Jun 2023 | - | $1.27B(+3.9%) |
| Mar 2023 | - | $1.22B(-5.1%) |
| Dec 2022 | $1.29B(+3.9%) | $1.29B(+5.7%) |
| Sep 2022 | - | $1.22B(-0.4%) |
| Jun 2022 | - | $1.22B(+3.5%) |
| Mar 2022 | - | $1.18B(-4.6%) |
| Dec 2021 | $1.24B(-0.6%) | $1.24B(+1.7%) |
| Sep 2021 | - | $1.22B(+1.1%) |
| Jun 2021 | - | $1.21B(+0.8%) |
| Mar 2021 | - | $1.20B(-4.1%) |
| Dec 2020 | $1.25B(+5.8%) | $1.25B(+10.6%) |
| Sep 2020 | - | $1.13B(+0.2%) |
| Jun 2020 | - | $1.13B(+4.5%) |
| Mar 2020 | - | $1.08B(-8.6%) |
| Dec 2019 | $1.18B(+82.3%) | $1.18B(-8.2%) |
| Sep 2019 | - | $1.28B(-3.6%) |
| Jun 2019 | - | $1.33B(-4.1%) |
| Mar 2019 | - | $1.39B(+114.8%) |
| Dec 2018 | $646.50M(-16.8%) | $646.50M(-7.7%) |
| Sep 2018 | - | $700.10M(+6.1%) |
| Jun 2018 | - | $660.10M(+4.5%) |
| Mar 2018 | - | $631.60M(-18.8%) |
| Dec 2017 | $777.50M(+57.0%) | $777.50M(-8.2%) |
| Sep 2017 | - | $846.90M(-5.5%) |
| Jun 2017 | - | $896.20M(+84.7%) |
| Mar 2017 | - | $485.10M(-2.0%) |
| Dec 2016 | $495.10M(-20.0%) | $495.10M(+18.0%) |
| Sep 2016 | - | $419.60M(+9.2%) |
| Jun 2016 | - | $384.40M(-18.1%) |
| Mar 2016 | - | $469.30M(-24.2%) |
| Dec 2015 | $619.25M(+0.1%) | $619.25M(-8.9%) |
| Sep 2015 | - | $679.86M(-0.5%) |
| Jun 2015 | - | $683.26M(-12.7%) |
| Mar 2015 | - | $782.56M(+26.5%) |
| Dec 2014 | $618.84M(-21.0%) | $618.84M(-27.7%) |
| Sep 2014 | - | $855.49M(+15.6%) |
| Jun 2014 | - | $739.80M(-2.3%) |
| Mar 2014 | - | $757.24M(-3.3%) |
| Dec 2013 | $783.26M(+47.3%) | $783.26M(+26.4%) |
| Sep 2013 | - | $619.54M(+10.3%) |
| Jun 2013 | - | $561.53M(+4.8%) |
| Mar 2013 | - | $535.77M(+0.8%) |
| Dec 2012 | $531.73M | $531.73M(-7.6%) |
| Sep 2012 | - | $575.78M(+7.4%) |
| Jun 2012 | - | $535.92M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $525.90M(-5.9%) |
| Dec 2011 | $558.71M(+66.9%) | $558.71M(-2.2%) |
| Sep 2011 | - | $571.20M(+1.0%) |
| Jun 2011 | - | $565.51M(+2.8%) |
| Mar 2011 | - | $550.31M(+64.4%) |
| Dec 2010 | $334.73M(-13.7%) | $334.73M(-22.4%) |
| Sep 2010 | - | $431.17M(+9.3%) |
| Jun 2010 | - | $394.49M(+101.3%) |
| Mar 2010 | - | $196.01M(-49.4%) |
| Dec 2009 | $387.65M(+9.9%) | $387.65M(+119.9%) |
| Sep 2009 | - | $176.28M(+9.2%) |
| Jun 2009 | - | $161.38M(+12.3%) |
| Mar 2009 | - | $143.69M(-59.3%) |
| Dec 2008 | $352.74M(+25.8%) | $352.74M(+54.2%) |
| Sep 2008 | - | $228.79M(-25.1%) |
| Jun 2008 | - | $305.53M(+1.6%) |
| Mar 2008 | - | $300.75M(+7.3%) |
| Dec 2007 | $280.35M(+2.3%) | $280.35M(-3.8%) |
| Sep 2007 | - | $291.29M(+39.3%) |
| Jun 2007 | - | $209.04M(-23.7%) |
| Mar 2007 | - | $273.91M(-0.0%) |
| Dec 2006 | $273.94M(+1579.5%) | $273.94M(+1105.3%) |
| Sep 2006 | - | $22.73M(-12.3%) |
| Jun 2006 | - | $25.91M(+380.8%) |
| Mar 2006 | - | $5.39M(-67.0%) |
| Dec 2005 | $16.31M(+5.1%) | $16.31M(-13.3%) |
| Sep 2005 | - | $18.82M(+8.0%) |
| Jun 2005 | - | $17.43M(+28.0%) |
| Mar 2005 | - | $13.62M(-12.3%) |
| Dec 2004 | $15.52M(+32.2%) | $15.52M(-1.6%) |
| Sep 2004 | - | $15.77M(+24.5%) |
| Jun 2004 | - | $12.66M(+15.3%) |
| Mar 2004 | - | $10.99M(-6.4%) |
| Dec 2003 | $11.74M(-9.1%) | $11.74M(-36.7%) |
| Sep 2003 | - | $18.54M(+21.9%) |
| Jun 2003 | - | $15.20M(+11.2%) |
| Mar 2003 | - | $13.67M(+5.9%) |
| Dec 2002 | $12.91M(-17.9%) | $12.91M(-3.4%) |
| Sep 2002 | - | $13.36M(-8.3%) |
| Jun 2002 | - | $14.57M(+27.8%) |
| Mar 2002 | - | $11.40M(-27.5%) |
| Dec 2001 | $15.72M(-1.2%) | $15.72M(+8.4%) |
| Sep 2001 | - | $14.51M(-10.7%) |
| Jun 2001 | - | $16.25M(+0.2%) |
| Mar 2001 | - | $16.21M(+1.9%) |
| Dec 2000 | $15.91M(+149.4%) | $15.91M(+64.5%) |
| Sep 2000 | - | $9.67M(+12.9%) |
| Jun 2000 | - | $8.56M(+25.5%) |
| Mar 2000 | - | $6.82M(+7.0%) |
| Dec 1999 | $6.38M(+207.9%) | $6.38M(+55.5%) |
| Sep 1999 | - | $4.10M(+148.8%) |
| Jun 1999 | - | $1.65M(-28.2%) |
| Mar 1999 | - | $2.30M |
| Dec 1998 | $2.07M | - |
FAQ
- What is United Therapeutics Corporation annual total liabilities?
- What is the all time high annual total liabilities for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual total liabilities year-on-year change?
- What is United Therapeutics Corporation quarterly total liabilities?
- What is the all time high quarterly total liabilities for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly total liabilities year-on-year change?
What is United Therapeutics Corporation annual total liabilities?
The current annual total liabilities of UTHR is $994.40M
What is the all time high annual total liabilities for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual total liabilities is $1.29B
What is United Therapeutics Corporation annual total liabilities year-on-year change?
Over the past year, UTHR annual total liabilities has changed by -$230.20M (-18.80%)
What is United Therapeutics Corporation quarterly total liabilities?
The current quarterly total liabilities of UTHR is $734.40M
What is the all time high quarterly total liabilities for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly total liabilities is $1.39B
What is United Therapeutics Corporation quarterly total liabilities year-on-year change?
Over the past year, UTHR quarterly total liabilities has changed by -$291.60M (-28.42%)